Lario Therapeutics Limited
- Company number
- SC716204
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 26 Nov 2021
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- GMV Nominees Ltd (47903 companies)
Registered office
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr. Henning Klaus-Willi Christian Steinhagen | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
26 Nov 2021 | 25 Mar 2022 |
| Epidarex Capital Iii Uk, Lp | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
28 Mar 2022 |
Accounts
| Year ended | Cash | Employees |
|---|---|---|
| 31 Dec 2024 | £1,364,922 | 0 |
Connections
Owned by
Lario Therapeutics Limited → Epidarex Capital Iii UK, LP → British Business Finance Ltd → British Business Bank PLC
Companies at the same address
- Adorx Therapeutics Limited (SC558719)
- Edinburgh Molecular Imaging Limited (SC467269)
- EIF Co-Invest LP (SL033412)
- Epidarex Capital Fp, LLP (SO304175)
- Epidarex Capital Ii Gp, LP (SL033675)
- Epidarex Capital Ii, LP (SL011942)
- Epidarex Capital Iii UK Gp, LP (SL033676)
- Epidarex Capital Iii UK, LP (SL033678)
- Epidarex Capital Iv, LP (SL037721)
- Epidarex Capital Partners Limited (SC437985)